The Third External Review

Overview
The report first focuses on TDR’s general mandate and disease portfolio. The next sections examine TDR’s activities and its development of scientific knowledge - its contributions to the development of disease control tools and progress in the development of new drugs and vaccines. It demonstrates how numerous collaborators have sustained and contributed to the final outcomes. This is followed by a review of TDR’s research capability strengthening activities, including recommendations for the future. TDR’s organizational structure, the interface with control programmes and other management issues are examined in the last sections.
The following reference documents form an integral part of the final report:
- The burden of tropical diseases among the poorest and richest 20% of the global population
Davidson R. Gwatkin and Michel Guillot, International Health Policy Program, Washington D.C. TDR, 1998 (TDR/ER/RD/98.1)
- TDR’s impact on science - a bibliometric study
Catherine Michaud, Harvard University, TDR, 1998 (TDR/ER/RD/98.2)
- TDR’s contributions to the development of ivermectin for onchocerciasis
Tomoko Fujisaki and Michael R. Reich, Takemi Program in International Health, Harvard School of Public Health, TDR, 1998 (TDR/ER/RD/98.3)
- TDR’s contributions to the development of multidrug therapy for the control of leprosy
Rania Milleron, Tomoko Fujisaki and Michael R. Reich, Takemi Program in International Health, Harvard School of Public Health, TDR, 1998 (TDR/ER/RD/98.4)
- TDR’s contributions to the development of the fumigant canister for controlling Chagas disease
Tomoko Fujisaki and Michael R. Reich, Takemi Program in International Health, Harvard School of Public Health, TDR, 1998 (TDR/ER/RD/98.5)
Comments by JCB(21) on the report of the Third External Review led to the development of the TDR Strategy for 2000-2005.
Those wishing to find out more about the processes involved in evaluating global and regional partnerships are referred to a recent publication by the World Bank.